Poll: How comfortable are you with including biosimilars in your treatment plans?

Roman-Lantzy, PhD, gives an urgent plea to eye care providers, whom she calls "the gatekeepers of the entire story" for pediatric patients with CVI.

A comparison of ETDRS charts using Latin letters, Tumbling E, and Landolt C optotypes found the alternatives are comparable to letter acuity at the population level.

Vision testing results from 384 public transport drivers in Mumbai found the Visiolite 4K screener accurately matched standard assessments while cutting screening time by 65%.

Jem Martin, OD, discusses the accommodations and referrals any provider can offer, the red flags that should raise suspicion of CVI, and how the free TEACHCVI screening tool works in practice.

Heru's PretestPro runs 4 pretesting exams in about 90 seconds on the Heru Prime wearable platform and reaches all current and future customers via free software update.

The latest in drug and technology developments and updates from August 2026.

Merabet, OD, PhD, MPH, discusses what his research on motion processing reveals about the neural roots of CVI and where diagnostic tools like neuroimaging and eye tracking are headed.

Host Hamza Shah, OD, MS, FAAO, is joined by Leonard Messner, OD, to discuss GLP-1s and idiopathic intracranial hypertension, inspired by Mitchell et al's paper, "The Effect of GLP-1RA Exenatide on Idiopathic Intracranial Hypertension: A Randomized Clinical Trial."